EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Amplified Ferroptosis and Apoptosis Facilitated by Differentiation Therapy Efficiently Suppress the Progression of Osteosarcoma

Chao He iD, Yuhang Jiang, Yuan Guo, Zenghui Wu

Small · 2023

DOI: 10.1002/smll.202302575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2023. Verfasst von Chao He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Translational Research Center of Regenerative Medicine and 3D Printing of Guangzhou Medical University, Guangdong P…. Hauptthemen laut MEDLINE: Ferroptosis, Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science and Technology Projects in Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is the most frequent osseous neoplasm among young people aged 10–20. Currently, the leading treatment for osteosarcoma is a combination of surgery and chemotherapy. However, the mortality remains high due to chemoresistance, metastasis, and recurrence, attributing to the existence of cancer stem cells (CSCs) as reported. To target CSCs, differentiation therapy attracts increasing attention, inducing CSCs to bulk tumor cells with elevated reactive oxygen species (ROS) levels and less chemoresistance. Moreover, increasing studies have implied that ferroptosis is a promising approach to eliminating cancer cells through eliciting oxidative damage and subsequent apoptosis, effectively bypassing chemoresistance. Here, a cancer‐cell‐membrane‐decorated biocompatible formulation (GA‐Fe@CMRALi liposome) is constructed to combat OS efficiently by combining distinct differentiation and ferroptosis therapies through magnified ROS‐triggered ferroptosis and apoptosis with homologous target capability to tumor sites. The combinational approach exhibited favorable therapeutic efficacy against OS in vitro and in vivo. Impressively, the potential mechanisms are revealed by mRNA sequencing. This study provides a tactical design and typical paradigm of the synergized differentiation and ferroptosis therapies to combat heterogeneous OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisOsteosarcomaBone NeoplasmsHumansAdolescentReactive Oxygen SpeciesApoptosisCell DifferentiationCell Line, Tumor

Stichwörter der Autor:innen

apoptosisdifferentiation therapyferroptosis therapyosteosarcomareactive oxygen species (ROS)

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Translational Research Center of Regenerative Medicine and 3D Printing of Guangzhou Medical University, Guangdong Province Engineering Research Center for Biomedical Engineering, The Th…
  • Department of Orthopedic Surgery, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.

ORCID-Profile: Chao He

Förderung

  • Science and Technology Projects in Guangzhou

Zitieren

APA

He, C., Jiang, Y., Guo, Y., & Wu, Z. (2023). Amplified Ferroptosis and Apoptosis Facilitated by Differentiation Therapy Efficiently Suppress the Progression of Osteosarcoma. Small. https://doi.org/10.1002/smll.202302575

Vancouver

He C, Jiang Y, Guo Y, Wu Z. Amplified Ferroptosis and Apoptosis Facilitated by Differentiation Therapy Efficiently Suppress the Progression of Osteosarcoma. Small. 2023. doi:10.1002/smll.202302575

BibTeX
@article{He2023,
  author = {He, Chao and Jiang, Yuhang and Guo, Yuan and Wu, Zenghui},
  title = {Amplified Ferroptosis and Apoptosis Facilitated by Differentiation Therapy Efficiently Suppress the Progression of Osteosarcoma},
  journal = {Small},
  year = {2023},
  doi = {10.1002/smll.202302575}
}
Kostenlos starten →